2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethanamine
Also known as: - Nitrosamine Impurities or nitrosamine impurities of -| Product Name | 2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethanamine |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-46705 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 219.24 g/mol |
| Mol. For. | C11H13N3O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethanamine is a synthetic compound that belongs to the class of indole derivatives. The chemical formula of this compound is C11H13N3O3 and its molecular weight is 235.24 g/mol.
This compound has been used in various research studies as a potential anti-cancer agent due to its ability to inhibit the growth of cancer cells. It has also been studied for its potential use in the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease.
The chemical structure of 2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethanamine contains a nitroso group (-NO) which is known to have strong oxidizing properties. This group may play a role in the compound's ability to inhibit the growth of cancer cells through oxidative stress.
The compound is typically synthesized through a multi-step process that involves the reaction of 5-methoxyindole-3-carbaldehyde with hydroxylamine hydrochloride to form the nitroso derivative. This is followed by the reaction of the nitroso derivative with ethylenediamine to form the final product.
In conclusion, 2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethanamine is a synthetic compound that has shown potential for use in the treatment of cancer and neurological disorders. Its chemical structure contains a nitroso group which may play a role in its biological activity. Further research is needed to fully understand the compound's mechanisms of action and potential therapeutic applications.
Get an Instant Quote
Related Compounds
Nu-chek mix 17A impurity | Diethyl P-(2-cyclopropyl-2-oxoethyl) phosphonate | Nimodipine Impurity 6 | Methyl 2',3'-dichloro-5-methyl-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate | N-nitroso-4- hydrazinobenzenesulfonamide | Larotrectinib (3S,2S) Sulfate | methyl (1S,2S,5R)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate | Methyl 3-(4-methoxyphenyl)-2-methyloxirane-2-carboxylate | Desfluoro Pibrenstavir Impurity | N2',N2'''-[Dithiobis(1-oxo-3,1-propanediyl)]bis[N2'-deacetyl-maytansine | Ulinastatin JP Reference standard (3700 units) | Methyl 4-[(2R,4S)-4-ethoxy-2-piperidinyl]benzoate | Triethyl 1,3,5-benzenetricarboxylate | eCF506 | Fmoc-O-tert-butyl-D-trans-4-hydroxyproline | Sacubitril Impurity 13 | Bis-anhydro-Daunomycinone Carboxylic Acid | methyl 3,4-dihydro-2H-1,4-benzothiazine-6-carboxylate | Diethoxyethane | Triethanolamine phosphate | AD-021.32-D6 | Trimethylolpropane ethoxy triacrylate | Heptacarboxylporphyrin I Dihydrochloride | D-Cysteine Methyl Ester | Sugammadex vinyl impurity | Methyl 4-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate | N-(Benzo[d]isoxazol-3-yl)-N-methylmethanesulfonamide | Deformyl Formoterol Citric acid adduct | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | N-(4H-1,2,4-triazol-4-yl)nitrous amide | N-((1S)-1-carboxy-2-methyl propyl)-N,N-bis[(2'-cyanobiphenyl-4-yl)methyl]-1-oxopentan-1-aminium chloride | Sacubitril Impurity 57 | Fmoc-Gly-OH-1-13C | N-Nitroso Silodosin Nitrile Impurity | N-(4-hydroxybutyl)-N-isopropylnitrous amide | Resmetirom Impurity 3 | Cevimeline disulfide dimer | Hydrocortisone Impurity - 18 | Di-isonocyl phthalate | Phytonadione (S) Hydroxy impurity | Larotrectinib hydrogen sulfate Impurity | Secnidazole Isomer Formate | Demethyloleuropein Aglycone | dCBP-1 | Sacubitril Impurity 14 | Chloromethylisothiazolinone-methylisothiazolinone Mixture | Nandrolone hydrogen succinate | ethyl 7-((5-methyl-4,4-dioxido-5,10-dihydrobenzo[c]thieno[2,3-f][1,2]thiazepin-10-yl)amino)heptanoate | Methyl 7-methylcyclopenta[c]pyran-4-carboxylate | N-propyl cyclooct-2-en-1-amine | N-ethyl-N-isopropyl ethylenediamine | Maleic anhydride-styrene copolymer | Ethyl N-[2-cyano-2-[2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]hydrazinylidene]acetyl]carbamate | Dydrogesterone Impurity C | N-nitroso Indoline | N-(4-acetamidobenzoyl)-L-glutamic acid | Nonylphenol | Nandrolone caproate | Prenderol | propane-1,2,3-triyl triethane sulfonate | Fidaxomicin Related Compound L | N-Nitroso Vilazodone Impurity 3 | Butyric-3,3-d2 Acid | Xanthoangelol | Triiodothyroacetic acid sulfate | ethyl 2-chloro-2-(2-(4-chlorophenyl)hydrazineylidene)acetate | Adrenalin Nitroso Impurity 1 | Methyl 4-chloro-3-oxopentanoate | N-Nitroso N-Desmethyl Mianserin | methyl 4-((5-(4-nitrobenzoyl)-1H-indol-1-yl)methyl)benzoate |